SCM
CCXI

Silverarc Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Silverarc Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,036
Closed -$645K – 104
2022
Q2 		$645K Buy
+26,036
New +$574K 0.3% 61
2021
Q4 		– Hold
0
– – – 95
2021
Q3 		– Hold
0
– – – 118
2021
Q2 		– Sell
-55,974
Closed -$1.38M – 128
2021
Q1 		$2.87M Buy
55,974
+2,208
+4% +$133K 1.61% 25
2020
Q4 		$3.33M Buy
+53,766
New +$3.08M 2.03% 19

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SFM
Soros Fund Management New York $7.29B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $60.6B AUM 31.35% 1-Year Est. Return